Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transcriptional Addiction in Cancer
James E. Bradner, Denes Hnisz, Richard A. Young
Cell (2017) Vol. 168, Iss. 4, pp. 629-643
Open Access | Times Cited: 1039

Showing 1-25 of 1039 citing articles:

Coactivator condensation at super-enhancers links phase separation and gene control
Benjamin R. Sabari, Alessandra Dall’Agnese, Ann Boija, et al.
Science (2018) Vol. 361, Iss. 6400
Open Access | Times Cited: 2174
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta, Artem Sokolov, Andrew J. Gentles, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 338-354.e15
Open Access | Times Cited: 1765
Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains
Ann Boija, Isaac A. Klein, Benjamin R. Sabari, et al.
Cell (2018) Vol. 175, Iss. 7, pp. 1842-1855.e16
Open Access | Times Cited: 1581
Epigenetic plasticity and the hallmarks of cancer
William Flavahan, Elizabeth Gaskell, B Bernstein
Science (2017) Vol. 357, Iss. 6348
Open Access | Times Cited: 1157
Kinase inhibitors: the road ahead
Fleur M. Ferguson, Nathanael S. Gray
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 5, pp. 353-377
Closed Access | Times Cited: 895
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet, Justin M. Roberts, Dennis L. Buckley, et al.
Nature Chemical Biology (2018) Vol. 14, Iss. 5, pp. 431-441
Open Access | Times Cited: 878
RNA in cancer
Gregory J. Goodall, Vihandha O. Wickramasinghe
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 22-36
Closed Access | Times Cited: 839
YAP/TAZ upstream signals and downstream responses
Antonio Totaro, Tito Panciera, Stefano Piccolo
Nature Cell Biology (2018) Vol. 20, Iss. 8, pp. 888-899
Open Access | Times Cited: 834
Organization and regulation of gene transcription
Patrick Cramer
Nature (2019) Vol. 573, Iss. 7772, pp. 45-54
Closed Access | Times Cited: 621
The great escape: tumour cell plasticity in resistance to targeted therapy
Soufiane Boumahdi, Frédéric J. de Sauvage
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 39-56
Closed Access | Times Cited: 606
Determinants of enhancer and promoter activities of regulatory elements
Robin Andersson, Albin Sandelin
Nature Reviews Genetics (2019) Vol. 21, Iss. 2, pp. 71-87
Closed Access | Times Cited: 602
Partitioning of cancer therapeutics in nuclear condensates
Isaac A. Klein, Ann Boija, Lena K. Afeyan, et al.
Science (2020) Vol. 368, Iss. 6497, pp. 1386-1392
Open Access | Times Cited: 417
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
Georg Winter, Andreas Mayer, Dennis L. Buckley, et al.
Molecular Cell (2017) Vol. 67, Iss. 1, pp. 5-18.e19
Open Access | Times Cited: 416
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Helai P. Mohammad, Olena Barbash, Caretha L. Creasy
Nature Medicine (2019) Vol. 25, Iss. 3, pp. 403-418
Closed Access | Times Cited: 382
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Adelajda Zorba, Chuong Nguyen, Yingrong Xu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 31
Open Access | Times Cited: 357
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Xin Li, Yongcheng Song
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 337
Widespread transcriptional pausing and elongation control at enhancers
Telmo Henriques, Benjamin S. Scruggs, Michiko O. Inouye, et al.
Genes & Development (2018) Vol. 32, Iss. 1, pp. 26-41
Open Access | Times Cited: 310
Targeting Transcription Factors for Cancer Treatment
Mélanie Lambert, Samy Jambon, Sabine Depauw, et al.
Molecules (2018) Vol. 23, Iss. 6, pp. 1479-1479
Open Access | Times Cited: 310
Super-Enhancer-Driven Transcriptional Dependencies in Cancer
Satyaki Sengupta, Rani E. George
Trends in cancer (2017) Vol. 3, Iss. 4, pp. 269-281
Open Access | Times Cited: 295
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Carsten Bahr, Lisa von Paleske, Veli Vural Uslu, et al.
Nature (2018) Vol. 553, Iss. 7689, pp. 515-520
Closed Access | Times Cited: 293
Epigenetic drivers of tumourigenesis and cancer metastasis
Aniruddha Chatterjee, Euan J. Rodger, Michael R. Eccles
Seminars in Cancer Biology (2017) Vol. 51, pp. 149-159
Open Access | Times Cited: 283
PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E. Gryder, Marielle E. Yohe, Hsien-Chao Chou, et al.
Cancer Discovery (2017) Vol. 7, Iss. 8, pp. 884-899
Open Access | Times Cited: 277
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4
Francesca Zanconato, Giusy Battilana, Mattia Forcato, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1599-1610
Open Access | Times Cited: 276
Advances in targeting ‘undruggable’ transcription factors with small molecules
Matthew J. Henley, Angela N. Koehler
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 669-688
Closed Access | Times Cited: 267
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Sohum Mehta, Jin Zhang
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 239-252
Open Access | Times Cited: 259
Page 1 - Next Page

Scroll to top